MoxifloxacinAcquired drug resistance: 5 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1912卷 / 1期

关键词：

D O I：

10.1007/s40278-022-18005-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：302 / 302

相关论文

共 50 条

[41] ErdafitinibAcquired drug resistance: 2 case reports
Reactions Weekly, 2024, 2037 (1) : 172 - 172
[42] AntiviralsDevelopment of drug resistance: 3 case reports
Reactions Weekly, 2020, 1809 (1) : 46 - 46
[43] AntitubercularsAcquired drug resistance: 9 case reports
Reactions Weekly, 2023, 1982 (1) : 63 - 63
[44] Multiple drugsChronic hepatitis E virus infection and drug resistance: 5 case reports
Reactions Weekly, 2020, 1789 (1) : 175 - 175
[45] Adefovir/entecavir/lamivudineAcquired drug resistance resulting in a viral breakthrough: 5 case reports
Reactions Weekly, 2022, 1924 (1) : 26 - 26
[46] Isoniazid/PrednisoloneActive tuberculosis, acquired drug resistance and lack of efficacy: 5 case reports
Reactions Weekly, 2024, 2028 (1) : 263 - 263
[47] FluconazoleFixed drug eruptions: 5 case reports
Reactions Weekly, 2008, 1186 (1) : 21 - 21
[48] Multiple drugsAcquired drug resistance, drug resistance and treatment failure: 16 case reports
Reactions Weekly, 2025, 2047 (1) : 271 - 272
[49] ValaciclovirDevelopment of viral resistance: 5 case reports
Reactions Weekly, 2017, 1677 (1) : 262 - 262
[50] Multiple drugsDrug resistance: 5 case reports
Reactions Weekly, 2021, 1880 (1) : 261 - 261

← 1 2 3 4 5 →